Classic EM Journal Reviews

March 7th, 2024 Leave a Comment

High risk and low prevalence diseases: Blast injuries

Blast injuries stem from the instantaneous transformation of a substance from solid or liquid to gas, releasing energy in the form of heat, light, pressure, and sound. While rare, blast injuries carry a high rate of morbidity and mortality.
Read More

February 9th, 2024 Leave a Comment
January 8th, 2024 Leave a Comment
September 29th, 2023 One Comment
July 24th, 2023 Leave a Comment

Diabetic ketoacidosis (DKA) is an endocrine emergency. The  standard of care of treating DKA is fluid resuscitation, electrolyte management, and intravenous insulin infusion in the intensive care unit (ICU) setting for close glucose and electrolyte monitoring. Recent research aims at investigating the treatment of DKA with subcutaneous insulin in non-ICU settings. 

 
Read More

Tags: , , , November 22nd, 2021 Leave a Comment

D-Dimer to Rule Out Venous Thromboembolism During Pregnancy: A Systematic Review and Meta-Analysis

Pregnant women have a higher risk of venous thromboembolism (VTE) and an increasing D-Dimer over the course of pregnancy. The majority of clinical guidelines recommend the D-dimer should not be used to assess the risk of VTE in pregnant women. However, CTPE presents a radiation risk to both the mother and fetus. Unfortunately, most VTE studies exclude pregnant women.
Read More

Tags: , September 13th, 2019 Leave a Comment

Dexamethasone in Adults with Bacterial Meningitis

Morbidity and mortality rates are high among adult patients with acute bacterial meningitis especially those with pneumococcal meningitis. Animal studies have shown that bacterial lysis occuring with antibiotic treatment leads to inflammation in the subarachnoid space and that treatment with dexamethasone, an anti-inflammatory agent, reduced cerebrospinal fluid inflammation and neurologic sequelae (Tauber, et al., J Infect Dis.,
Read More

August 8th, 2019 Leave a Comment

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Stroke is one of the leading causes of death in the United States. Approximately 87% of all strokes are ischemic. Available therapies are limited and include thrombolysis and thrombectomy. There is a known risk of hemorrhagic conversion of acute ischemic strokes with the use of thrombolytics. Of the 12 clinical trials comparing thrombolysis vs. either placebo or no treatment for acute ischemic stroke,
Read More